Department of Pharmaceutics and Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.
Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
NPJ Syst Biol Appl. 2022 Aug 16;8(1):29. doi: 10.1038/s41540-022-00235-8.
Critical functions of the blood-brain barrier (BBB), including cerebral blood flow, energy metabolism, and immunomodulation, are regulated by insulin signaling pathways. Therefore, endothelial insulin resistance could lead to BBB dysfunction, which is associated with neurodegenerative diseases such as Alzheimer's disease (AD). The current study aims to map the dynamics of insulin-responsive pathways in polarized human cerebral microvascular endothelial cell (hCMEC/D3) monolayers. RNA-Sequencing was performed on hCMEC/D3 monolayers with and without insulin treatment at various time points. The Short Time-series Expression Miner (STEM) method was used to identify gene clusters with distinct and representative expression patterns. Functional annotation and pathway analysis of genes from selected clusters were conducted using Webgestalt and Ingenuity Pathway Analysis (IPA) software. Quantitative expression differences of 16,570 genes between insulin-treated and control monolayers were determined at five-time points. The STEM software identified 12 significant clusters with 6880 genes that displayed distinct temporal patterns upon insulin exposure, and the clusters were further divided into three groups. Gene ontology (GO) enrichment analysis demonstrated that biological processes protecting BBB functions such as regulation of vascular development and actin cytoskeleton reorganization were upregulated after insulin treatment (Group 1 and 2). In contrast, GO pathways related to inflammation, such as response to interferon-gamma, were downregulated (Group 3). The IPA analyses further identified insulin-responsive cellular and molecular pathways that are associated with AD pathology. These findings unravel the dynamics of insulin action on the BBB endothelium and inform about downstream signaling cascades that are potentially disrupted due to brain insulin resistance prevalent in AD.
血脑屏障(BBB)的关键功能,包括脑血流、能量代谢和免疫调节,受胰岛素信号通路调节。因此,内皮细胞胰岛素抵抗可能导致 BBB 功能障碍,与阿尔茨海默病(AD)等神经退行性疾病有关。本研究旨在描绘极化人脑血管内皮细胞(hCMEC/D3)单层中胰岛素反应途径的动态变化。对有和没有胰岛素处理的 hCMEC/D3 单层在不同时间点进行 RNA 测序。使用 Short Time-series Expression Miner(STEM)方法识别具有独特和代表性表达模式的基因簇。使用 Webgestalt 和 Ingenuity Pathway Analysis(IPA)软件对来自选定簇的基因进行功能注释和途径分析。在五个时间点测定胰岛素处理和对照单层之间 16570 个基因的定量表达差异。STEM 软件确定了 12 个具有 6880 个基因的显著簇,这些基因在胰岛素暴露后显示出明显的时间模式,并且这些簇进一步分为三组。基因本体(GO)富集分析表明,保护 BBB 功能的生物学过程,如血管发育和肌动蛋白细胞骨架重排的调节,在胰岛素处理后上调(第 1 组和第 2 组)。相比之下,与炎症相关的 GO 途径,如干扰素-γ反应,下调(第 3 组)。IPA 分析进一步确定了与 AD 病理学相关的胰岛素反应性细胞和分子途径。这些发现揭示了胰岛素对 BBB 内皮的作用动态,并提供了关于由于 AD 中普遍存在的大脑胰岛素抵抗而潜在破坏的下游信号级联的信息。